Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-18

Clinical Trial Update: Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility Study [Phase 3]

View source ↗

Summary

A Phase 3 feasibility study is evaluating adjunctive mild hypothermia therapy added to primary percutaneous coronary intervention in patients with acute myocard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mild hypothermia therapy

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Myocardial Infarction Complicated With Cardiogenic Shock | Phase 3 | Status: UNKNOWN